Skip to search formSkip to main contentSkip to account menu

lysinomicin

Known as: D-myo-Inositol, 5-amino-6-O-(6-(aminomethyl)-3-((3,6-diamino-1-oxohexyl)amino)-3,4-dihydro-2H-pyran-2-yl)-2,5-dideoxy-3-O-methyl-2-(methylamino)-, (2R-cis)-, D-myo-Inositol, 5-amino-6-O-(6-(aminomethyl)-3-((3,6-diamino-1-oxohexyl)amino)-3,4-dihydro-2H-pyran-2-yl)-2,5-dideoxy-3-O-methyl-2-(methylamino)-, (2S-(2alpha,3alpha(R*)))- 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Aminoglycosides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
The pseudodisaccharides: a novel class of group I intron splicing inhibitors.
Lysinomicin, a naturally-occurring pseudodisaccharide, inhibits translation in prokaryotes. We report that lysinomicin (and three… 
1984
1984
Lysinomicin, a new aminoglycoside antibiotic. II. Structure and stereochemistry.
The structure of lysinomicin, a new aminocyclitol antibiotic, was established as 3-epi-2'-N-(L-beta-lysyl)-4',5'-didehydro-6'-de… 
1982
1982
4-N-Aminoacylation of substances derived from lysinomicin.
The preparations of 4-N-glycyllysinomicin and several 4-N-aminoacyl derivatives of compounds prepared from lysinomicin are… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)